Sumatriptan
Sumatriptan is a pharmaceutical drug with 34 clinical trials. Currently 2 active trials ongoing. Historical success rate of 93.8%.
Success Metrics
Based on 30 completed trials
Phase Distribution
Phase Distribution
11
Early Stage
3
Mid Stage
8
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
93.8%
30 of 32 finished
6.3%
2 ended early
2
trials recruiting
34
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I
Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache
A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs
Clinical Trials (34)
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine
Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO) Phase I
Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache
A Study on the Effects of Repeat Doses of Intraject® Sumatriptan on Local Site Signs
Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin
Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine
Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy
Efficacy and Safety of BGG492 in the Treatment of Migraine
Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman
A STUDY TO EVALUATE THE EFFECT OF PF-06651600 ON PHARMACOKINETICS OF SINGLE DOSE SUMATRIPTAN IN HEALTHY PARTICIPANTS.
Study in Participants With Acute Migraines Headaches
The Role of Inflammation and Vasodilatation in PACAP38-induced Headache Using MRI on Healthy Subjects
Effect of Single Oral Doses of Lasmiditan When Coadministered With Single Oral Doses of Sumatriptan in Healthy Participants
A Study of Lasmiditan When Given With Sumatriptan in Healthy Participants
Cerebral Pharmacodynamic Effects of 5-HT1B Receptor Stimulation
Study to Evaluate the Effect of Erenumab on Blood Pressure When Given Concomitantly With Subcutaneous Sumatriptan
Study to Evaluate the Safety, Tolerability, and Blood Pressure Effect of an Oral Dose of Sumatriptan Alone and in Combination With MK-0974 (Telcagepant) in Migraine Patients (0974-026)
Trial of Comprehensive Migraine Intervention
Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 34